AMACR versus COX-2 expression in benign prostatic hyperplasia and prostatic adenocarcinoma: a comparative study

Conclusion: Early detection can be made by estimation of AMACR antibody, and treatment must be focused more on AMACR than on COX-2 inhibitors.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: Original Articles Source Type: research